⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 2, 2024Biomedicine & PharmacotherapyOpen Access

Dysfunctional regulatory T cell: May be an obstacle to immunotherapy in cardiovascular diseases

Yu-sha Zhang Yaqin Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

Inflammatory responses are linked to cardiovascular diseases (CVDs) in various forms. Tregs, members of CD4

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e7603ab6db6435876d68c0 https://doi.org/10.1016/j.biopha.2024.116359

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeting regulatory T cells for cardiovascular diseasesreview · 2023 · 38 citations
2Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications2024 · 15 citations
3Regulatory T cells and peripheral immune tolerance: key mechanisms and therapeutic strategies for cardiovascular diseasesreview · 2026 · 2 citations
4Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathypreclinical · 2019 · 300 citations
5An emerging role of regulatory T-cells in cardiovascular repair and regenerationreview · 2020 · 43 citations

More related papers

Current Status of Treg Therapy in Transplantation and Autoimmune Disease2026
Regulatory T cells in cardiac allograft vasculopathy: from mechanistic insights to clinical tolerance2026
Regulatory T cells in cancer and inflammation2026

More from Biomedicine & Pharmacotherapy

Hydrogen sulfide in bone homeostasis: Mechanisms and therapeutic potentialThu,
Hepatocellular carcinoma (HCC) spheroid model exhibits a characteristic extracellular matrix-rich fibrous capsule hindering drug penetrationWed,